Genomic and Phenotypic Analysis of COVID-19-Associated Pulmonary Aspergillosis Isolates of Aspergillus fumigatus
Male
Antifungal Agents
virulence factors
Secondary Metabolism
Microbial Sensitivity Tests
Microbiology
Polymorphism, Single Nucleotide
Article
superinfection
secondary infection
pathogenicity
Humans
Metabolomics
Aged
Virulence
SARS-CoV-2
Aspergillus fumigatus
COVID-19
Genomics
acute respiratory distress syndrome
Middle Aged
coinfection
QR1-502
3. Good health
Aspergillus
Phenotype
Mutation
Female
Pulmonary Aspergillosis
Research Article
DOI:
10.1128/spectrum.00010-21
Publication Date:
2021-06-13T22:42:19Z
AUTHORS (17)
ABSTRACT
The global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiological agent of coronavirus disease 2019 (COVID-19), has already killed millions of people. COVID-19 patient outcome can be further complicated by secondary infections, such as COVID-19-associated pulmonary aspergillosis (CAPA).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (112)
CITATIONS (38)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....